DPM, Principal Investigator, Limb Preservation Platform, Inc., Fresno, CA, US
We have shown that the CWC rate was significantly increased in dACM-treated subjects compared with subjects treated with SoC alone in a challenging patient population with DFUs of >6 weeks' duration...
Prospectively collected data from patients enrolled in two Institutional Review Board-approved RCTs (EFDFU003 and ECDFU001),14,22 and Medicare claims from 2015–2019 were retrospectively evaluated..